Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1

Apr.14
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands released a trading update on April 14, reiterating its FY26 guidance and saying its 2030 transformation has started positively. The company said it still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year.

Key Takeaways

 

  • Imperial Brands reiterated its FY26 guidance for low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% Group adjusted operating profit growth, at least high-single-digit EPS growth, and at least GBP 2.2 billion in free cash flow. 
  • The company said tobacco and NGP net revenue are expected to grow by a low-single-digit percentage in H1, while Group adjusted operating profit should be slightly higher year on year and accelerate in H2. 
  • Imperial Brands said it has completed GBP 0.7 billion of its GBP 1.45 billion FY26 share buyback, including the remaining GBP 0.1 billion announced in October 2024. 
  • The company said Europe and AAACE are driving NGP performance, supported by Pulze 3.0, the blu kit range, and new Skruf and Zone launches. 
  • Imperial Brands will announce interim results for the six months ended March 31, 2026 on May 12, 2026. 

 


 

2Firsts, April 14, 2026 

 

According to Imperial Brands’ trading update, the company reiterated its full-year FY26 guidance and said it has made a positive start to its 2030 transformation. Imperial Brands said it continues to expect low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year. 

 

The company also said the conflict in the Middle East has made the geopolitical and macroeconomic environment more uncertain, although there has been no material business impact so far, and that it will provide a further update with its H1 results on May 12. 

 

Low-single-digit H1 growth is expected, with stronger momentum in H2

 

The company said tobacco and NGP net revenue in H1 are expected to grow by a low-single-digit percentage. Tobacco net revenue is expected to show low-single-digit growth, supported by robust pricing and a low-single-digit decline in combustible volumes. NGP net revenue is expected to grow by a mid-to-high single-digit percentage, with double-digit growth in the Europe and AAACE regions. Imperial Brands said this performance is being driven by continued momentum in heated tobacco through Pulze 3.0, particularly in Italy and Greece; by the blu kit range in vape; and by recent launches of Skruf and Zone in modern oral across the Nordics and the UK. 

 

The company also said that while market share remains important, it continues to balance share and value and is increasingly focusing on more profitable segments after stabilizing aggregate share across its top five markets. As a result, it expects some modest overall aggregate share reduction across those markets in H1, alongside growth in tobacco adjusted operating profit. Group adjusted operating profit is expected to be slightly higher year on year, with strong performance in Europe and the wider AAACE portfolio partly offset by the U.S., Australia, and Logista. The company said performance remains weighted to the second half. 

 

U.S. performance, buybacks, and cash flow remain in focus

 

Imperial Brands said that in the United States, Zone continues to perform well and maintain volume share, although NGP net revenue is expected to be lower than the same period last year because of heightened promotional activity. The company said tobacco and NGP net revenue and adjusted operating profit growth in the U.S. are expected to accelerate in the second half, supported by combustible price increases already taken in H1, planned H2 price increases, the March launch of the Malibu cigarette brand, and recent new flavor launches for Zone together with a targeted channel strategy. 

 

Imperial Brands also said its adjusted operating cash conversion remains strong on a 12-month basis, and it remains on track to deliver at least GBP 2.2 billion in free cash flow for the full year. On share repurchases, the company said it completed the remaining GBP 0.1 billion announced in October 2024 and had completed GBP 0.7 billion of its GBP 1.45 billion FY26 programme as of March 31, 2026. Imperial Brands said the combined total represents about 3.2% of issued share capital as of September 30, 2025, and reiterated its commitment to returning surplus capital through its ongoing evergreen share buyback programme to 2030 alongside a progressive dividend policy. 

 

The company says its 2030 transformation has started well

 

Imperial Brands said it has made a good start to its 2030 strategy and continues to move toward becoming a more consumer-centric, data-led, agile, and efficient challenger. During the first half, it began implementing its new long-term partnership with Capgemini, took further action on its supply chain footprint, and continued the rollout of enterprise IT applications. The company also confirmed that interim results for the six months ended March 31, 2026 will be announced on May 12, 2026. 

 

Image Source: Imperial Brands

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Russian Interior Ministry spokesperson Irina Volk said on May 6 that police in Moscow seized about 65,000 nicotine-containing products from a man during searches of residential and warehouse premises. The products were valued at about RUB 30 million, or about USD 395,727 based on an exchange rate of USD 1 = RUB 75.81.
May.11 by 2FIRSTS.ai
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
The Geneva Court of Justice on Tuesday upheld appeals filed by four associations and companies active in the tobacco trade and annulled the Geneva legal provision banning the sale of disposable e-cigarettes, commonly known as “puffs.”
Apr.30 by 2FIRSTS.ai
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris said it is accelerating its transition toward smoke-free products in Spain and claimed that the related economic impact now exceeds EUR 3.3 billion. Philip Morris also said that more than 90% of nicotine consumption in Spain still comes from conventional cigarettes, leaving room for growth in smoke-free categories, while regulation and taxation remain major obstacles in its view.
Apr.21 by 2FIRSTS.ai
Japan Tobacco Releases Three Ploom AURA Collaboration Panels Inspired by “Sake”
Japan Tobacco Releases Three Ploom AURA Collaboration Panels Inspired by “Sake”
Japan Tobacco announced that it will sponsor “CRAFT SAKE WEEK 2026,” to be held at Roppongi Hills Arena, and set up a dedicated smoking area called “Ploom LOUNGE.” Three Ploom AURA collaboration front panels inspired by the theme of “sake” will be offered at the venue, along with trial use, sales, and related original content.
Apr.13 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13